2,3-dinor-thromboxane b2 has been researched along with icatibant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dechaux, E; Dowell, FJ; Henrion, D; Lévy, BI; Maclour, J; Michel, JB; Samuel, JL | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and icatibant
| Article | Year |
|---|---|
Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase 1; Cyclooxygenase 2; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Isoenzymes; Isoquinolines; Male; Membrane Proteins; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Prostaglandin-Endoperoxide Synthases; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Thromboxane B2; Vascular Resistance; Vasodilation | 1997 |